[opensourcepharma] J&J/U.Toronto collaboration

[Dr. Urmi Bajpai]

Dear Melinda,

These are great initiatives n will help further bridge the gap between
academia n industry,  which is so much desired. More so if the academic
institutions are given freedom to experiment n research.

Much appreciate your efforts and wish you success,  which am sure will
come. Grants and a degree of flexibility for academics can reap rich
dividends for every one to benefit from in the long run.

Best
Urmi
On Tuesday, September 9, 2014, Richter, Melinda [JRDUS] <
MRicht23 at its.jnj.com <javascript:_e(%7B%7D,'cvml','MRicht23 at its.jnj.com');>>
wrote:

>  Hi Els,
>
>
>
> Yes, that is one of our projects.  J&J has partnered with a newly formed
> organization CCDR (U of T’s Center for Collaborative Drug Research), which
> is an amalgamation of many institutions (academic, research, hospitals) in
> the Toronto area, to fund any proposals that are meeting important unmet
> medical needs in mood disorders and Alzheimer’s.  We will do a call for
> applications  twice a year, the first call starting November 6th with
> first papers due January 6th.  These simple 1-3 page proposals will which
> will go in front of the Joint Steering Committee, which is comprised of J&J
> and UofT representatives.  We will pick the top 10 for more extensive
> applications for which the JSC will offer their resources to help flush
> out.  These applications can be of any type (therapeutics, diagnostics,
> care management, etc.) and can be for any size or dollar amount.
>
>
>
> The JSC will pick a top selection (top 3-6 projects) with the final
> contenders to be chosen by the CCDR.  J&J has put up the initial pot of
> money but we are requiring a local match for each grant for which we’re
> dedicated to helping raise and are in the process of soliciting those
> matches now.  In addition, we are also opening up our resources at J&J
> including access to compound libraries, expert resources, etc. which can
> also include residency at Janssen Labs.
>
>
>
> These are all grants with no strings attached.  The Toronto area has a
> number of research institutions that are completely based on the open
> source model and have been quite successful at it, so this is based on
> their experience and history in this domain.  In fact, the Structural
> Genomics Consortium in Toronto has been particularly successful at it and
> is an interesting case study.
>
>
>
> This is another experiment of ours for which, if successful, we’ll invite
> other pharmas to participate.  We did a similar experiment last year called
> the Cognition Challenge which was a smaller version of this.  This is an
> expansion of that project.
>
>
>
> Let me know if you have other questions and also happy to talk live.
>
>
>
> M.
>
>
>
> *MELINDA RICHTER | Head of Janssen Labs*
>
>
>
> [image: cid:image002.png at 01CE8EB4.BF3F57A0]
>
> 858.242.1501
>
>
>
>
>
> *From:* Els Torreele [mailto:els.torreele at opensocietyfoundations.org]
> *Sent:* Monday, September 08, 2014 6:17 PM
> *To:* Richter, Melinda [JRDUS]
> *Cc:* opensourcepharma at lists.okfn.org
> *Subject:* J&J/U.Toronto collaboration
>
>
>
> <="" style="">
>
> Hi Melinda,
>
>
>
> I saw the announcement for an open source research collaboration between
> Janssen and Toronto University:
>
>
> http://www.newswire.ca/en/story/1407678/janssen-inc-and-johnson-johnson-innovation-establish-research-collaboration-with-the-university-of-toronto
>
>
>
> Is that one of your projects?
>
> Seems truly fascinating - can you tell us a bit more about it?
>
> How is the open source going to work in practice?
>
> And how will the ownership/IP of the results be dealt with?
>
>
>
> best wishes
>
> Els
>
>
>
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.okfn.org/pipermail/opensourcepharma/attachments/20140909/13e251b3/attachment-0002.html>